Background {#Sec1}
==========

Esophagectomy is the standard therapy for patients with localized esophageal cancer, but it is a highly invasive procedure and associated with serious postoperative complications such as pulmonary complications, anastomotic leaks, and sepsis \[[@CR1]\]. Major pulmonary complications after esophagectomy have been implicated in prolonged hospital stays and postoperative mortality \[[@CR2], [@CR3]\]. The preoperative health status is important because advanced age, preoperative chemoradiotherapy, and comorbidity of chronic obstructive pulmonary disease (COPD) are associated with the increased risk of postoperative complications and mortality \[[@CR4], [@CR5]\]. Moreover, it has been reported that a lack of preoperative physical activity and the loss of maximum oxygen uptake are risk factors for pulmonary or cardiopulmonary complications \[[@CR6]--[@CR8]\].

Perioperative rehabilitation has been expected to improve physical fitness, promote early mobilization, and reduce postoperative pulmonary complications in patients with esophageal cancer \[[@CR9], [@CR10]\]. In order to manage the rehabilitation program, it is important to adequately assess the status of functional exercise capacity and health-related quality of life (QOL) before surgery. Moreover, esophagectomy itself worsens health-related QOL and physical fitness \[[@CR11]--[@CR13]\]. A prospective study by Reynolds et al. demonstrated that esophageal resection had a negative impact on health-related QOL as assessed by the 30-item European Organization for the Research and Treatment of Cancer (EORTC) QOL Core Questionnaires (QLQ) (EORTC QLQ-C30) \[[@CR14]\] and esophageal cancer-specific EORTC QLQ (EORTC QLQ-OES24) \[[@CR15]\] 3 months after surgery \[[@CR12]\]. Moreover, Teoh et al. reported that esophagectomy was associated with worsened physical functioning and fatigue symptoms as assessed by EORTC QLQ-C30 and QLQ-OES24 up to 6 months after treatment \[[@CR11]\]. Tatematsu et al. reported that 6MWD and knee-extensor muscle strength were significantly decreased approximately 3 weeks after esophagectomy \[[@CR13]\]. However, the pre- and postoperative physical fitness, health-related QOL, psychological aspects, and their relationships have not been fully evaluated in patients with esophageal cancer who have undergone esophagectomy.

The purpose of the present study was to characterize the preoperative functional exercise capacity, muscle strength, anxiety, depression, and health-related QOL in patients with esophageal cancer, and to evaluate the impact of radical esophagectomy on these parameters 2 weeks after the surgery.

Methods {#Sec2}
=======

Patients {#Sec3}
--------

Records of 43 consecutive patients with esophageal cancer who underwent scheduled radical esophagectomy in the Department of Gastroenterological Surgery II, Nagoya University Hospital from January to December 2014 were retrospectively reviewed. Patients who underwent emergency surgery were not included. At our institution, perioperative pulmonary rehabilitation is routinely performed on patients who underwent esophagectomy. In addition, physical, mental, and QOL status are routinely assessed before and after surgery as the perioperative rehabilitation program according to previous reports and guidelines \[[@CR2], [@CR10], [@CR13], [@CR16]--[@CR19]\]. Patients are allowed to refuse the assessment if they do not wish. A flow chart describing the inclusion process is shown in Fig. [1](#Fig1){ref-type="fig"}. Thirty-four patients who underwent pre- and postoperative physical assessment were evaluated. Nine patients were excluded because they were discharged within 14 days after surgery (*n* = 3), were unable to walk without assistance due to invasive pharyngolaryngectomy (*n* = 2), were postoperatively admitted to the Intensive Care Unit (*n* = 2), and had atrial fibrillation (*n* = 1), and physiological status was evaluated 3 weeks after surgery (*n* = 1). The tumors were staged according to the seventh edition of the Union for International Cancer Control TNM staging system, and the tumor grades were classified according to the WHO classification of histological differentiation. The severity of postoperative complications was classified using the Clavien-Dindo classification \[[@CR20]\]. Information about patients was collected through a review of electronic medical records.Fig. 1Flow of participants

Pulmonary function tests {#Sec4}
------------------------

Preoperative pulmonary functions were routinely measured using computerized equipment (Fudak77, Fukuda Sangyo, Tokyo, Japan) at the clinical laboratory within 30 days before the operation. As spirometric parameters, vital capacity (VC), forced vital capacity (FVC), and forced expiratory volume in 1 s (FEV~1~) were measured. COPD was defined as an FEV~1~/FVC ratio \<70 % without any other respiratory diseases. The predicted values for spirometry and lung volumes were calculated according to the method of the Japanese Respiratory Society \[[@CR21]\].

Measurements of physical fitness {#Sec5}
--------------------------------

The 6-min walk distance (6MWD) was measured by the 6-min walk test (6MWT) according to guidelines of the American Thoracic Society \[[@CR22]\]. During the 6MWT, oxygen saturation of a peripheral artery (SpO~2~) was measured using a pulse oximeter (Pulsox-Me300; Teijin Pharma Co., Tokyo, Japan) without supplemental oxygen. Desaturation was defined as a fall in SpO~2~ ≥ 4 % or SpO~2~ \< 90 % during the 6MWT \[[@CR23]\]. Isometric knee extensor muscle strength was assessed using a hand-held dynamometer (Mutus F-100; Anima Co., Tokyo, Japan). Hand grip strength was measured using a digital dynamometer (Grip-D, Takei Co., Niigata, Japan).

Assessment of anxiety, depression, and health-related QOL {#Sec6}
---------------------------------------------------------

Anxiety and depression were measured using the validated Japanese version of the Hospital Anxiety and Depression Scale (HADS) \[[@CR24]\]. The scores range from 0 to 21 for each subscale, with a score ≥8 denoting a probable case. A higher score represents a higher level of anxiety or depression. Health-related QOL was assessed by the validated Japanese version of the MOS 36-item Short-Form Health Survey (SF-36) version 2, which has eight subscales and three component summary scores: a physical component summary (PCS), mental component summary (MCS), and role/social component summary (RCS) \[[@CR25]\]. A higher SF-36 score represents a better health-related QOL. Respiratory health-related QOL was assessed by a validated Japanese version of the COPD assessment test (CAT), an eight-item questionnaire including cough, phlegm, chest tightness, breathlessness, activity limitation, confidence to leave home, sleep, and energy \[[@CR26]\]. A higher CAT score represents a poorer respiratory health-related QOL.

Rehabilitation program {#Sec7}
----------------------

Pre- and postoperative rehabilitation was performed by specialized physical therapists (T.I., M.N, Y.M., K.H., and H.N.). The preoperative pulmonary rehabilitation protocol included (1) measurements of 6MWD, knee extensor muscle strength, and hand grip strength, (2) assessment of HADS, SF-36, and CAT, and (3) orientation to the postoperative rehabilitation program and encouragement of early mobilization. Preoperative measurements were assessed 1 to 10 days before the surgery. All patients performed the postoperative pulmonary rehabilitation, which consisted of positioning, stretching of respiratory muscles and thoracic cage, deep diaphragmatic breathing, coughing and huffing, and early mobilization from the first postoperative day. When possible, 6MWD, muscle strength, HADS, and CAT were re-evaluated 14 days after the operation.

Statistical analysis {#Sec8}
--------------------

Data were expressed as means ± SD or median (range). The paired *t*-test or Fisher's exact test was used to evaluate statistical significance. When data failed a normality test, the Mann-Whitney U test was performed. Correlations between variables were analyzed using Spearman's rank correlation coefficient. Regression analysis was used for univariate analysis and multiple regression analysis (forced entry method) was used for multivariate analysis. All analyses were conducted using SPSS ver. 19 (SPSS Inc., Tokyo, Japan). *P* \< 0.05 was considered statistically significant.

Results {#Sec9}
=======

Clinical characteristics {#Sec10}
------------------------

The characteristics and results of preoperative pulmonary function and laboratory tests of the 34 patients are shown in Table [1](#Tab1){ref-type="table"}. The patients were predominantly male (76.4 %), had a high rate of smoking history (91.2 %), and squamous cell carcinoma (97.1 %). COPD was present in 12 patients (35.3 %). The preoperative clinical stage was 0-I in 12 patients, II in 4 patients, III in 16 patients, and IV in 2 patients. Twenty-two patients (64.7 %) received some sort of induction therapy (chemotherapy or chemoradiotherapy). Thirty-one patients (91.2 %) underwent open surgery. Three (8.8 %) patients experienced postoperative pulmonary complications. Two patients developed pneumonia (Clavien-Dindo Grade II) and one patient pneumothorax (Grade I). There was no in-hospital death or reoperation after esophagectomy.Table 1Clinical characteristics of 34 subjectsVariableSex, male/female*N* = 26/8Age, years (range)67.3 ± 8.1 (50--84)Height, cm163.2 ± 7.9Weight, kg54.9 ± 7.6Body mass index20.6 ± 2.2Smoking history*N* = 31Squamous cell carcinoma/adenocarcinoma*N* = 33/1Clinical stage, 0-I/II/III/IV*N* = 12/4/16/2Lymphadenectomy, 1/2/3 fields*N* = 1/24/9Preoperative adjuvant therapy*N* = 22COPD*N* = 12%VC101.5 ± 14.1%FEV~1~94.0 ± 15.9FEV~1~/FVC, %73.0 ± 7.9Open surgery/video-assisted thoracic surgery*N* = 31/3Operation time, min520 ± 90Blood loss during surgery, ml719 ± 456Intensive Care Unit stay, days1.3 ± 0.6Timing of extubation, 0/1/2 postoperative days*N* = 23/9/2Hospital stay after surgery, days21.2 ± 15.0Walking with support, postoperative days1.9 ± 1.8Values are numbers (N) or mean ± SD. Total numbers of subjects are 34. *COPD* chronic obstructive pulmonary disease, *VC* vital capacity, *FEV* ~*1*~ forced expiratory volume in one second, *FVC* forced vital capacity

Correlations between preoperative parameters {#Sec11}
--------------------------------------------

Correlations between various parameters before the surgery are shown in Table [2](#Tab2){ref-type="table"}. The preoperative 6MWD significantly correlated with hand grip strength (right: *r* = 0.562, *P* = 0.001, left: *r* = 0.511, *P* = 0.002), isometric knee extensor muscle strength (right: *r* = 0.482, *P* = 0.006, left: *r* = 0.535, *P* = 0.002), and SF-36 components, physical functioning (*r* = 0.454, *P* = 0.013), general health (*r* = 0.465, *P* = 0.011), mental health (*r* = 0.382, *P* = 0.045), and MCS (*r* = 0.497, *P* = 0.010). CAT scores showed significant inverse correlation with hand grip strength (right: *r* = -0.490, *P* = 0.005, left: *r* = -0.406, *P* = 0.002) and isometric knee extensor muscle strength (right: *r* = -0.491, *P* = 0.008, left: *r* = -0.565, *P* = 0.002). Correlations between QOL parameters or 6MWD and pulmonary functions before surgery are shown in Table [3](#Tab3){ref-type="table"}. Correlations between SF-36 scores and CAT or HADS before surgery are shown in Table [4](#Tab4){ref-type="table"}. Total CAT scores showed significant inverse correlation with most SF-36 components: physical functioning (*r* = -0.384, *P* = 0.040), general health (*r* = -0.432, *P* = 0.019), social functioning (*r* = -0.658, *P* \< 0.001), vitality (*r* = -0.503, *P* = 0.005), role emotional (*r* = -0.381, *P* = 0.041), mental health (*r* = -0.510, *P* = 0.006), MCS (*r* = -0.584, *P* = 0.002), and RCS (*r* = -0.433, *P* = 0.027). HADS anxiety and depression significantly correlated with most SF-36 components. In contrast, HADS anxiety and depression did not significantly correlate with CAT scores.Table 2Correlation between preoperative parametersParameters6MWDHand grip strengthIsometric knee extensor muscle strengthRightLeftRightLeft6MWDr10.5620.5110.4820.535*P* value00.001 (*n* = 34)0.002 (*n* = 34)0.006 (*n* = 31)0.002 (*n* = 31)CAT scoresr−0.332−0.490−0.406−0.491−0.565*P* value0.068 (*n* = 31)0.005 (*n* = 31)0.024 (*n* = 31)0.008 (*n* = 28)0.002 (*n* = 28)SF-36 component Physical functioningr0.4540.1370.2580.3500.365*P* value0.013 (*n* = 29)0.478 (*n* = 29)0.177 (*n* = 29)0.080 (*n* = 26)0.067 (*n* = 26) Role physicalr0.3340.4130.4900.5890.473*P* value0.076 (*n* = 29)0.026 (*n* = 29)0.007 (*n* = 29)0.002 (*n* = 26)0.015 (*n* = 26) Bodily painr0.1260.1230.1660.1720.125*P* value0.516 (*n* = 29)0.525 (*n* = 29)0.389 (*n* = 29)0.401 (*n* = 26)0.542 (*n* = 26) General healthr0.4650.3820.3670.4780.376*P* value0.011 (*n* = 29)0.041 (*n* = 29)0.050 (*n* = 29)0.014 (*n* = 26)0.058 (*n* = 26) Social functioningr0.3340.2210.2210.3700.306*P* value0.077 (*n* = 29)0.249 (*n* = 29)0.248 (*n* = 29)0.063 (*n* = 26)0.128 (*n* = 26) Vitalityr0.2870.3560.3980.4330.283*P* value0.131 (*n* = 29)0.058 (*n* = 29)0.034 (*n* = 29)0.027 (*n* = 26)0.161 (*n* = 26) Role emotionalr0.2430.1970.3170.5150.385*P* value0.204 (*n* = 29)0.305 (*n* = 29)0.093 (*n* = 29)0.007 (*n* = 26)0.052 (*n* = 26) Mental healthr0.3820.1240.3170.3550.310*P* value0.045 (*n* = 28)0.529 (*n* = 28)0.093 (*n* = 28)0.081 (*n* = 25)0.131 (*n* = 25) PCSr0.1590.3450.3460.2840.228*P* value0.436 (*n* = 26)0.084 (*n* = 26)0.083 (*n* = 26)0.189 (*n* = 23)0.296 (*n* = 23) MCSr0.4970.2200.1800.3540.349*P* value0.010 (*n* = 26)0.281 (*n* = 26)0.379 (*n* = 26)0.097 (*n* = 23)0.103 (*n* = 23) RCSr0.2920.2250.3450.5870.435*P* value0.148 (*n* = 26)0.269 (*n* = 26)0.084 (*n* = 26)0.003 (*n* = 23)0.038 (*n* = 23)Spearman's rank correlation coefficient was used for the analysis. *6MWD* 6-min walk distance, *CAT* COPD assessment test, *SF-36* the MOS 36-item Short-Form Health Survey Questionnaire, *PCS* physical component summary, *MCS* mental component summary, *RCS*, role/social component summary Table 3Correlation between preoperative parameters and pulmonary functionsParametersVC%VCFEV~1~%FEV~1~FEV~1~/FVC6MWD (*n* = 34)r0.5020.0980.5790.0150.291*P* value0.0020.581\<0.0010.9340.095CAT scores (*n* = 31)r− 0.418− 0.334− 0.415− 0.269− 0.265*P* value0.0190.0660.0200.1430.149SF-36 component Physical functioning (*n* = 29)r0.3670.3100.4230.1840.184*P* value0.0500.1020.0220.3390.340 Role physical (*n* = 29)r0.4030.0090.197− 0.315− 0.236*P* value0.0300.9640.3050.0960.218 Bodily pain (*n* = 29)r− 0.001− 0.050− 0.027− 0.246− 0.220*P* value0.9970.7980.8910.1990.251 General health (*n* = 29)r0.174− 0.0790.142− 0.223− 0.070*P* value0.3670.6840.4620.2440.717 Social functioning (*n* = 29)r0.1770.2750.2100.1800.106*P* value0.3580.1490.2750.3500.585 Vitality (*n* = 29)r0.3290.1120.255− 0.122− 0.099*P* value0.0810.5620.1820.5270.611 Role emotional (*n* = 29)r0.2680.0070.150− 0.186− 0.197*P* value0.1600.9730.4370.3350.307 Mental health (*n* = 28)r0.3340.3100.3680.2450.212*P* value0.0820.1080.0540.2080.279 PCS (*n* = 26)r0.095− 0.1360.022− 0.426− 0.276*P* value0.6450.5080.9160.0300.173 MCS (*n* = 28)r0.2170.2840.2910.2000.157*P* value0.2860.1590.1490.3270.443 RCS (*n* = 26)r0.4350.0750.290− 0.165− 0.121*P* value0.0260.7170.1500.4200.556Spearman's rank correlation coefficient was used for the analysis. *VC* vital capacity, *%VC* % of the predicted value for VC, *FEV* ~*1*~ forced expiratory volume in 1 s, *%FEV* ~*1*~ % of the predicted value for FEV~1~, *FVC* forced vital capacity Table 4Correlation between SF-36 and CAT or HADS before surgerySF-36 componentCATHADS anxietyHADS depressionPhysical functioningr−0.384−0.339−0.500*P* value0.0400.0720.006Role physicalr−0.323−0.745−0.557*P* value0.088\<0.0010.002Bodily painr−0.167−0.368−0.252*P* value0.3850.0490.187General healthr−0.432−0.543−0.321*P* value0.0190.0020.090Social functioningr−0.658−0.464−0.403*P* value\<0.0010.0110.030Vitalityr−0.503−0.448−0.554*P* value0.0050.0150.002Role emotionalr−0.381−0.593−0.470*P* value0.0410.0010.010Mental health (*n* = 28)r−0.510−0.379−0.563*P* value0.0060.0470.002PCS (*n* = 26)r−0.245−0.364−0.266*P* value0.2280.0670.188MCS (*n* = 26)r−0.584−0.361−0.317*P* value0.0020.0700.115RCS (*n* = 26)r−0.433−0.653−0.648*P* value0.027\<0.001\<0.001Spearman's rank correlation coefficient was used for the analysis. *N* = 29, otherwise indicated. *HADS* the Hospital Anxiety and Depression Scale

Correlations between postoperative parameters {#Sec12}
---------------------------------------------

Correlations between various parameters after the surgery are shown in Table [5](#Tab5){ref-type="table"}. The postoperative 6MWD significantly correlated with postoperative left isometric knee muscle extensor strength (*r* = 0.526, *P* = 0.003).Table 5Correlation between postoperative parametersParameters6MWDHand grip strengthIsometric knee extensor muscle strengthRightLeftRightLeft6MWDr10.1590.0710.3250.526*P* value00.394 (*n* = 31)0.704 (*n* = 31)0.085 (*n* = 29)0.003\* (*n* = 29)CAT scoresr−0.053−0.0200.014−0.421−0.383*P* value0.816 (*n* = 22)0.927 (*n* = 23)0.948 (*n* = 23)0.058 (*n* = 21)0.086 (*n* = 21)Spearman's rank correlation coefficient was used for the analysis. \**P* \< 0.05

Comparison between pre- and postoperative measurements {#Sec13}
------------------------------------------------------

Next, the effects of esophagectomy on physical and psychological status were examined. Comparisons and changes of 6MWD, desaturation during the 6MWT, muscle strength, HADS, and CAT before and after surgery are shown in Table [6](#Tab6){ref-type="table"}. The post-operative 6MWD (409 ± 108 m) was significantly shorter than the pre-operative value (496 ± 76 m, *P* \< 0.001). Muscle strength results showed that both right and left hand grip strengths were significantly decreased after the operation (*P* = 0.01). Left side isometric knee extensor muscle strength was significantly decreased after the operation (*P* = 0.02). That of the right side was also decreased after the operation, but the difference was not statistically significant level (*P* = 0.08). The number of patients whose HADS anxiety score was ≥8 increased from 4 to 8 after surgery, although the difference did not reach a statistically significant level by Fisher's exact test (*P* = 0.31). CAT scores significantly increased after surgery (*P* = 0.02).Table 6Comparison of 6MWD, muscle strength, and HADS before and after surgeryBeforeAfter surgery*P* valueChanges6MWD, m (*n* = 32)494 ± 76409 ± 1080.001 \> \*−85 ± 88Desaturation during 6MWT^a^*N* = 5*N* = 51Hand grip strength, kgf (*n* = 33) Right30.6 ± 9.128.7 ± 8.60.01\*−1.9 ± 3.9 Left28.8 ± 8.627.5 ± 7.70.01\*−1.3 ± 2.8Isometric knee extensor muscle strength, kgf (*n* = 31) Right26.0 ± 8.524.7 ± 8.20.08−1.3 ± 3.8 Left25.2 ± 9.422.9 ± 7.80.02\*−2.3 ± 4.9 HADS anxiety (*n* = 23)5.4 ± 2.95.1 ± 4.00.76−0.3 ± 4.0  Scores ≥ 8*N* = 4*N* = 80.31 HADS depression (*n* = 23)5.7 ± 3.75.4 ± 3.80.54−0.3 ± 2.3  Scores ≥ 8*N* = 6*N* = 71 CAT (*n* = 24)10.4 ± 5.615.9 ± 7.30.02\*5.5 ± 7.5Values are mean ± SD and compared by paired t-test or Fisher's exact test. ^a^Desaturation was defined as a fall in SpO~2~ ≥ 4 % or SpO~2~ \< 90 % during the 6MWT. \**P* \<0.05

Two different surgical techniques, open surgery for 31 patients and video-assisted thoracic (closed) surgery for three patients, were performed (Table [1](#Tab1){ref-type="table"}). Demographics and data of pre- and postoperative measurements of three patients who underwent video-assisted thoracic surgery are shown in Additional file [1](#MOESM1){ref-type="media"}: Table S1. The mean values of postoperative 6MWD and changes of 6MWD after the surgery were 364 m and −60 m. The mean changes of right and left hand grip strengths and right isometric knee extensor muscle strength were −3.8 kgf, −2.5 kgf, and −2.3 kgf, respectively. Left isometric knee extensor muscle strength was increased in two patients, and the mean changes were 1.0 kgf.

Effects of COPD and preoperative chemoradiotherapy {#Sec14}
--------------------------------------------------

The effects of comorbidity of COPD on physical and QOL parameters were examined. The parameters of patients with and without COPD are compared in Table [7](#Tab7){ref-type="table"}. Preoperative %FEV~1~ (*P* \< 0.001), FEV~1~/FVC (*P* \< 0.001), postoperative 6MWD (*P* = 0.034), and preoperative left isometric knee extensor muscle strength (*P* = 0.018) were significantly lower in patients with COPD than those without COPD. There was no significant difference in preoperative SF-36 components between the groups.Table 7Comparison of data with and without COPDNon-COPD (*n* = 22)COPD (*n* = 12)*P* valuePre %FEV~1~101.3 ± 12.775.2 ± 21.1\<0.001\*Pre FEV~1~/FVC, %77.3 ± 5.760.5 ± 16.3\<0.001\*Pre 6MWD, m509 ± 80466 ± 600.127Desaturation during 6MWT^a^*N* = 3*N* = 20.580Post 6MWD, m438 ± 100 (*n* = 21)351 ± 105 (*n* = 11)0.034\*Desaturation during 6MWT^a^*N* = 2*N* = 30.290Changes in 6MWD, m−70 ± 83 (*n* = 21)−114 ± 98 (*n* = 11)0.123Pre hand grip strength, kgf Right32.4 ± 8.428.4 ± 10.50.204 Left30.7 ± 8.827.0 ± 9.40.204Post hand grip strength, kgf Right29.6 ± 7.9 (*n* = 21)26.6 ± 9.70.152 Left28.7 ± 7.3 (*n* = 21)25.8 ± 8.00.242Pre isometric knee extensor muscle strength, kgf Right26.7 ± 8.2 (*n* = 20)24.7 ± 9.4 (*n* = 11)0.502 Left27.6 ± 8.9 (*n* = 20)20.1 ± 9.1 (*n* = 11)0.018\*Post isometric knee extensor muscle strength, kgf Right25.8 ± 8.3 (*n* = 20)22.8 ± 8.0 (*n* = 11)0.183 Left24.9 ± 7.7 (*n* = 20)19.3 ± 6.9 (*n* = 11)0.020\* Pre HADS anxiety6.1 ± 2.8 (*n* = 21)4.5 ± 3.2 (*n* = 10)0.135  Scores ≥ 8*N* = 5*N* = 21 Pre HADS depression5.6 ± 3.2 (*n* = 21)5.5 ± 4.1 (*n* = 10)0.852  Scores ≥ 8*N* = 5*N* = 40.781 Post HADS anxiety4.8 ± 3.3 (*n* = 15)5.6 ± 5.4 (*n* = 8)0.925  Scores ≥ 8*N* = 4*N* = 40.676 Post HADS depression5.7 ± 3.8 (*n* = 15)4.9 ± 4.1 (*n* = 8)0.681  Scores ≥ 8*N* = 5*N* = 21 Pre CAT (*n* = 31)8.1 ± 5.5 (*n* = 21)14.2 ± 5.5 (*n* = 10)0.008\* Post CAT (*n* = 24)14.1 ± 5.3 (*n* = 16)19.6 ± 9.6 (*n* = 8)0.136Pre SF-36 component Physical functioning49.5 ± 15.1 (*n* = 19)40.9 ± 15.5 (*n* = 10)0.308 Role physical37.6 ± 19.3 (*n* = 19)38.1 ± 21.6 (*n* = 10)0.456 Bodily pain44.8 ± 12.9 (*n* = 19)41.4 ± 24.5 (*n* = 10)0.804 General health45.3 ± 9.5 (*n* = 19)45.4 ± 11.4 (*n* = 10)0.946 Vitality43.2 ± 17.6 (*n* = 19)39.0 ± 18.4 (*n* = 10)0.804 Social functioning49.0 ± 11.2 (*n* = 19)38.8 ± 17.3 (*n* = 10)0.069 Role emotional41.3 ± 18.2 (*n* = 19)40.7 ± 17.0 (*n* = 10)0.604 Mental health49.3 ± 14.3 (*n* = 19)38.4 ± 12.7 (*n* = 9)0.061 PCS46.7 ± 5.8 (*n* = 19)52.5 ± 9.7 (*n* = 7)0.209 MCS51.2 ± 10.1 (*n* = 19)45.5 ± 9.6 (*n* = 7)0.073 RCS38.1 ± 12.4 (*n* = 19)36.3 ± 23.3 (*n* = 7)0.955Values are mean ± SD and compared by paired t-test, Mann-Whitney U test or Fisher's exact test. \**P* \< 0.05. ^a^Desaturation was defined as a fall in SpO~2~ ≥ 4 % or SpO~2~ \< 90 %. The HADS score ≥8 denotes a probable case. *Pre* preoperative, *Post* postoperative

We also compared the results of physical and QOL parameters of patients with and without preoperative chemotherapy or radiotherapy (Table [8](#Tab8){ref-type="table"}). Among preoperative SF-36 components, role emotional and PCS scores of patients undergoing chemoradiotherapy were significantly lower than those without (*P* = 0.019). There was no significant difference in other parameters between the groups.Table 8Comparison of data with and without chemoradiotherapyWithout (*n* = 12)Chemotherapy and/or radiotherapy (*n* = 22)*P* value%FEV~1~93.3 ± 20.494.5 ± 13.90.466FEV~1~/FVC, %69.8 ± 7.774.8 ± 7.80.136Pre 6MWD, m485 ± 59499 ± 820.790Desaturation during 6MWT^a^*N* = 4*N* = 11Post 6MWD, m389 ± 109421 ± 109 (*n* = 20)0.654Desaturation during 6MWT^a^*N* = 0*N* = 50.155Changes in 6MWD, m−97 ± 61−78 ± 104 (*n* = 20)0.158Pre hand grip strength, kgf Right33.0 ± 12.029.9 ± 7.40.327 Left31.8 ± 11.028.1 ± 7.80.261Post hand grip strength, kgf Right30.8 ± 11.3 (*n* = 11)27.7 ± 7.00.560 Left28.4 ± 8.9 (*n* = 11)27.1 ± 7.20.693Pre isometric knee extensor muscle strength, kgf Right30.0 ± 9.423.4 ± 7.0 (*n* = 20)0.059 Left28.8 ± 11.623.0 ± 7.2 (*n* = 20)0.269Post isometric knee extensor muscle strength, kgf Right28.3 ± 9.022.5 ± 7.0 (*n* = 20)0.120 Left25.4 ± 8.821.3 ± 6.8 (*n* = 20)0.287 Pre HADS anxiety4.9 ± 3.56.0 ± 2.6 (*n* = 19)0.367  Scores ≥8*N* = 3*N* = 41 Pre HADS depression4.5 ± 2.96.2 ± 3.7 (*n* = 19)0.287  Scores ≥8*N* = 3*N* = 51 Post HADS anxiety5.3 ± 4.8 (*n* = 7)5.0 ± 3.8 (*n* = 16)1  Scores ≥8*N* = 2*N* = 61 Post HADS depression3.3 ± 2.6 (*n* = 7)6.3 ± 4.0 (*n* = 16)0.103  Scores ≥8*N* = 2*N* = 90.682 Pre CAT (*n* = 31)9.3 ± 6.410.6 ± 6.1 (*n* = 19)0.509 Post CAT (*n* = 24)13.7 ± 8.6 (*n* = 6)16.7 ± 6.9 (*n* = 18)0.343Pre SF-36 component Physical functioning51.7 ± 20.1 (*n* = 11)43.4 ± 11.6 (*n* = 18)0.146 Role physical46.2 ± 25.3 (*n* = 11)32.6 ± 13.8 (*n* = 18)0.084 Bodily pain38.7 ± 21.0 (*n* = 11)46.7 ± 14.6 (*n* = 18)0.387 General health49.2 ± 7.9 (*n* = 11)42.9 ± 10.6 (*n* = 18)0.055 Vitality48.1 ± 19.0 (*n* = 11)37.9 ± 16.1 (*n* = 18)0.188 Social functioning45.0 ± 18.1 (*n* = 11)45.7 ± 11.7 (*n* = 18)0.580 Role emotional50.2 ± 19.7 (*n* = 11)35.5 ± 13.7 (*n* = 18)0.049\* Mental health47.1 ± 17.4 (*n* = 10)45.1 ± 13.2 (*n* = 18)1.000 PCS53.2 ± 6.6 (*n* = 8)46.0 ± 6.6 (*n* = 18)0.019\* MCS48.9 ± 8.5 (*n* = 8)50.0 ± 10.8 (*n* = 18)0.807 RCS44.3 ± 11.3 (*n* = 8)32.5 ± 16.0 (*n* = 18)0.090Values are mean ± SD and compared by paired t-test, Mann-Whitney U test or Fisher's exact test. ^a^Desaturation was defined as a fall in SpO~2~ ≥ 4 % or SpO~2~ \< 90 %

Factors affecting postoperative 6MWD {#Sec15}
------------------------------------

Next, we aimed to identify pre- and intraoperative factors affecting the postoperative loss of exercise capacity. Changes in 6MWD before and after surgery were chosen because the 6MWT is a validated method to assess functional exercise capacity and efficacy of pulmonary rehabilitation \[[@CR27]\]. Results of the univariate regression analysis showed that the preoperative PCS, a component of SF-36, significantly correlated with decrease of 6MWD (*r* = 0.437, *P* = 0.033) (Table [9](#Tab9){ref-type="table"}). On the other hand, preoperative 6MWD, pulmonary functions, muscle strength, COPD comorbidity, chemoradiotherapy, blood loss during surgery, and operation time did not predict changes in 6MWD (Table [9](#Tab9){ref-type="table"}). Multiple regression analysis including all relevant variables with *P* values \<0.10 in univariate analysis showed that only PCS significantly correlated with changes in 6MWD (*r* = 0.488, *P* = 0.027) (Table [9](#Tab9){ref-type="table"}). There was a trend toward a greater risk of loss of 6MWD as preoperative %VC decreased (*P* = 0.077).Table 9Correlations between changes in 6MWD after esophagectomy and other parametersParametersUnivariate analysisMultivariate analysisStandardized partial regression coefficient*P* valueStandardized partial regression coefficient*P* valuePreoperative parameters Body mass index−0.0560.760NDND %VC−0.3270.068−0.573 (*n* = 23)0.077 %FEV~1~−0.3020.0930.369 (*n* = 23)0.273 6MWD0.1530.403NDNDHand grip strength Right0.2730.130NDND Left0.2540.162NDNDIsometric knee extensor muscle strength Right (*n* = 29)0.0280.885NDND Left (*n* = 29)−0.1010.601NDND CAT (*n* = 29)0.2200.251NDNDSF-36 component Physical functioning (*n* = 27)−0.1860.353NDND Role physical (*n* = 27)−0.0080.968NDND Bodily pain (*n* = 27)0.2830.153NDND General health (*n* = 27)0.0490.809NDND Social functioning (*n* = 27)−0.2170.276NDND Vitality (*n* = 27)0.2100.293NDND Role emotional (*n* = 27)0.0280.891NDND Mental health (*n* = 26)−0.1450.480NDND PCS (*n* = 24)0.4370.033\*0.488 (*n* = 23)0.027\* MCS (*n* = 24)−0.0730.734NDND RCS (*n* = 24)0.1150.593NDND With-without COPD0.2410.184NDND With-without chemo-radio therapy−0.1030.575NDNDIntraoperative parameters Blood loss during surgery0.1450.428NDND Operation time0.1450.430NDNDPostoperative parameters Postoperative hospital stays0.0460.802NDNDChanges in hand grip strength Right (*n* = 31)0.1530.412NDND Left (*n* = 31)0.1430.442NDNDChanges in isometric knee extensor muscle strength Right (*n* = 29)0.0450.815NDND Left (*n* = 29)0.0890.646NDND Changes in CAT scores (*n* = 23)−0.2190.315NDNDThe multivariate analysis includes relevant variables with *P* values \<0.10 in univariate analysis (preoperative %VC and %FEV~1~, and PCS). *ND* not done. \**P* \< 0.05. *N* = 32 otherwise indicated

Discussion {#Sec16}
==========

The main findings of the present study of patients with esophageal cancer who underwent esophagectomy with perioperative pulmonary rehabilitation were: 1) 6MWD and skeletal muscle strength had significantly decreased and CAT scores had increased 2 weeks after surgery, 2) PCS, a component of SF-36, significantly correlated with the decrease of 6MWD, and 3) comorbidity of COPD had a significant impact on health-related QOL, muscle strength, and 6MWD. To our knowledge, this is the first study to characterize the status of physical fitness, exercise capacity, health-related QOL, anxiety, and depression in patients with esophageal cancer before and after the surgery.

The 6MWT is a simple but well validated method to assess functional exercise capacity in patients with pulmonary and cardiovascular diseases \[[@CR22]\] and the efficacy of pulmonary rehabilitation \[[@CR27]\]. In the present study, preoperative 6MWD positively correlated with hand grip and isometric knee extensor muscle strength. It is expected that postoperative pulmonary rehabilitation helped maintain and recover the physical status of patients. However, the postoperative 6MWD and muscle strength were significantly lower than the preoperative values. Importantly, a mean decrease in the 6MWD of 85 m exceeded the clinically important distance of 54 m \[[@CR28]\], demonstrating the significant short-term impact of esophagectomy on exercise capacity. Even in the three patients who underwent video-assisted thoracic surgery, the mean decrease in 6MWD was 60 m, above the clinically important value. Our results were consistent with the previous report by Tatematsu et al. that 6MWD and knee-extensor muscle strength, which were measured on the day of hospital discharge (median 21 days after surgery), were significantly decreased after esophagectomy \[[@CR13]\]. Tatematsu et al. also reported that the change in the physical functional score on EORTC QLQ-C30 was significantly affected by that in the 6MWD by multiple regression analysis \[[@CR13]\]. In our study, results of multiple and univariate regression analysis show that the loss of 6MWD was significantly affected by the preoperative SF-36 physical component PCS. In contrast, comorbidity of COPD, preoperative adjuvant therapy, pulmonary function test results, operation duration, or blood loss during surgery did not affect the change in 6MWD, consistent with the results of Tatematsu et al. These findings indicate that the 6MWT is a convenient and useful tool to assess the physical status in order to plan a perioperative rehabilitation program for patients with esophageal cancer.

Long-term cigarette smoking is an important risk factor for developing COPD as well as squamous cell carcinoma of the esophagus. It has been reported that COPD is one of the predictors of postoperative mortality after esophagectomy \[[@CR5]\]. In our study, 91.2 % of patients were smokers, and the prevalence of COPD was relatively high (35.3 %). Moreover, both physical and QOL parameters were affected by comorbidity with COPD. The CAT is a validated questionnaire designed to assess and quantify the impact of COPD symptoms on health-related QOL \[[@CR26]\]. The CAT scores strongly correlate with scores on the St. George Respiratory Questionnaire, a tool to evaluate the respiratory-related QOL \[[@CR26]\]. Significant correlations between scores of total CAT and SF-36, a measure of the general health-related QOL, were found in our cohort, consistent with findings in COPD patients \[[@CR29]\]. Preoperative CAT scores were significantly higher and postoperative 6MWD and left hand grip strength were significantly lower in patients with COPD than those without. In addition, postoperative CAT scores were significantly higher than preoperative scores, suggesting the impact of esophagectomy on respiratory-related QOL. Although the use of CAT for assessment of the respiratory-related QOL after surgery such as esophagectomy has not been validated yet, CAT was used before and after the surgery for the following reasons. First, almost all the patients in our cohort were smokers with a high prevalence of COPD. Second, pulmonary rehabilitation was the main objective of our perioperative rehabilitation program in order to prevent pulmonary complications after esophagectomy. Third, a recent study demonstrated that the CAT is beneficial to assess respiratory symptom and complications even in smokers without COPD \[[@CR30]\]. Future studies are required to validate the use of CAT to assess respiratory-related QOL in patients who receive perioperative pulmonary rehabilitation. It would also be useful to evaluate the correlation between scores of CAT and QOL questionnaires specific for cancer and esophageal diseases such as the EORTC QLQ-C30 \[[@CR14]\] and EORTC QLQ-OES24 \[[@CR15]\].

The long-term impacts of esophagectomy on physical, QOL, or mental status after discharge have been investigated by other groups \[[@CR11], [@CR15], [@CR31], [@CR32]\]. In contrast, there is little information on postoperative physical and QOL status before discharge. The major purpose of our study was to evaluate how the physical, mental, and QOL parameters have recovered 2 weeks after esophagectomy during the hospital stay. Severer cases were excluded from the analysis because of gait disturbance 2 weeks after the surgery (Fig. [1](#Fig1){ref-type="fig"}). The incidence of pulmonary complications (8.8 %) was lower than that in previous reports (15--36 %) \[[@CR4], [@CR33], [@CR34]\]. Thus, our patients reflect a relatively good clinical course shortly after the esophagectomy.

This study has several limitations. The data were collected retrospectively from patients who underwent esophagectomy. We did not aim to determine the factors that predict postoperative complications or examine the effectiveness of perioperative pulmonary rehabilitation either. It is impossible to clarify whether the rehabilitation was beneficial for health outcomes after the esophagectomy from the present study design. A previous study demonstrated that intensive prehabilitation reduced postoperative pulmonary complications after esophagectomy \[[@CR10]\], indicating that improvement of physical fitness before the surgery may lead to better clinical outcomes after esophagectomy. Our findings demonstrated both the physical and QOL status of in-hospital patients two weeks after esophagectomy with perioperative rehabilitation. Further improvements, both from the viewpoint of minimally invasive surgery and perioperative management, are warranted. Prospective studies with a larger number of subjects including patients both with and without pulmonary rehabilitation are necessary to characterize the risk factors of postoperative complications and to improve the perioperative rehabilitation programs.

Conclusion {#Sec17}
==========

Our results indicate that esophagectomy is detrimental to health-related QOL and physical fitness at two weeks after surgery. Further investigation is required to establish a strategy for perioperative rehabilitation to improve postoperative outcomes.
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Additional file 1:**Table S1.** Data of three patients who underwent video-assisted thoracic surgery. (DOCX 19 kb) Additional file 2:**Table S2.** The datasets of 34 patients. (XLSX 23 kb)

6MWD

:   6-min walk distance

6MWT

:   6-min walk test

CAT

:   COPD assessment test

COPD

:   Chronic obstructive pulmonary disease

EORTC QLQ

:   European Organization for the Research and Treatment of Cancer QOL Core Questionnaire

FEV~1~

:   Forced expiratory volume in one second

FVC

:   Forced vital capacity

HADS

:   Hospital Anxiety and Depression Scale

MCS

:   Mental component summary

PCS

:   Physical component summary

QOL

:   Quality of life

RCS

:   Role/social component summary

SF-36

:   The MOS 36-item Short-Form Health Survey version 2

SpO~2~

:   Oxygen saturation of a peripheral artery

VC

:   Vital capacity
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